🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carly Young

University of Cape Town

ORCID: 0000-0002-2338-8314

Also affiliated with South African Tuberculosis Vaccine Initiative, University of the Western Cape

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID/WGNV workshop report 2023”.

Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID/WGNV workshop report 2023

Frontiers in Tuberculosis(2023)10.3389/ftubr.2023.1303505
N/A
0DataRank · unranked
1 citations

Mbali N. Mkhonza, Paul Ogongo, Carly Young

Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report

Frontiers in Tuberculosis(2024)10.3389/ftubr.2024.1384036
N/A
0DataRank · unranked
5 citations

Carly Young, Shaun Palmer, Erick Auma, Shelly Malhotra, Rupali J. Limaye +12 more

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

The Lancet Global Health(2025)10.1016/s2214-109x(25)00046-4
N/A
0DataRank · unranked
17 citations

Virginie Rozot, Claire Imbratta, Frances Ratangee, Justin Shenje, Michèle Tameris +62 more

Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

EBioMedicine(2025)10.1016/j.ebiom.2025.105628
N/A
0DataRank · unranked
12 citations

Virginie Rozot, Claire Imbratta, Hennie Geldenhuys, Simon C. Mendelsohn, Angelique Kany Kany Luabeya +58 more

Driving innovation from discovery to access: Meeting report of the 7th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil)

(2025)10.12688/verixiv.1073.1
N/A
0DataRank · unranked
0 citations

Rebecca A. Clark, Bridgette J. Connell, Vanessa Mwebaza Muwanga, Arthur Coelho, Paul Ogongo +2 more

Driving innovation from discovery to access: Meeting report of the 7 th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil)

Gates Open Research(2025)10.12688/gatesopenres.16360.1
N/A
0DataRank · unranked
0 citations

Rebecca A. Clark, Bridgette J. Connell, Vanessa Mwebaza Muwanga, Arthur Coelho, Paul Ogongo +2 more